Dupilumab for Systemic Allergy Syndrome With Dermatitis.
Sign Up to like & getrecommendations! Published in 2019 at "Dermatitis"
DOI: 10.1097/der.0000000000000446
Abstract: Allergic contact dermatitis (ACD) has been traditionally identified as TH1-mediated delayed-type hypersensitivity reactions. There is currently no Food and Drug Administration-approved systemic therapy indicated for ACD. Among patients with ACD, there is a subgroup that… read more here.
Keywords: allergy syndrome; systemic allergy; syndrome dermatitis; acd ... See more keywords